Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

被引:302
作者
Calabresi, Paolo [1 ,2 ]
Di Filippo, Massimiliano [1 ,2 ]
Ghiglieri, Veronica [2 ]
Tambasco, Nicola [1 ]
Picconi, Barbara [2 ]
机构
[1] Univ Perugia, Osped Santa Maria della Misericordia, Neurol Clin, I-06156 Perugia, Italy
[2] Fdn Santa Lucia, IRCCS, Rome, Italy
关键词
DOPA-INDUCED DYSKINESIA; ABNORMAL INVOLUNTARY MOVEMENTS; STRIATAL SYNAPTIC PLASTICITY; ADENOSINE A(2A) RECEPTORS; NIGRA PARS RETICULATA; RAT MODEL; MOTOR COMPLICATIONS; SUBSTANTIA-NIGRA; L-3,4-DIHYDROXYPHENYLALANINE-INDUCED DYSKINESIA; 6-HYDROXYDOPAMINE-TREATED RATS;
D O I
10.1016/S1474-4422(10)70218-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Levodopa is the most effective drug for the treatment of Parkinson's disease. However, the long-term use of this dopamine precursor is complicated by highly disabling fluctuations and dyskinesias. Although preclinical and clinical findings suggest pulsatile stimulation of striatal postsynaptic receptors as a key mechanism underlying levodopa-induced dyskinesias, their pathogenesis is still unclear. In recent years, evidence from animal models of Parkinson's disease has provided important information to understand the effect of specific receptor and post-receptor molecular mechanisms underlying the development of dyskinetic movements. Recent preclinical and clinical data from promising lines of research focus on the differential role of presynaptic versus postsynaptic mechanisms, dopamine receptor subtypes, ionotropic and metabotropic glutamate receptors, and non-dopaminergic neurotransmitter systems in the pathophysiology of levodopa-induced dyskinesias.
引用
收藏
页码:1106 / 1117
页数:12
相关论文
共 105 条
[1]   EFFECTS OF L-DOPA ON EXTRACELLULAR DOPAMINE IN STRIATUM OF NORMAL AND 6-HYDROXYDOPAMINE-TREATED RATS [J].
ABERCROMBIE, ED ;
BONATZ, AE ;
ZIGMOND, MJ .
BRAIN RESEARCH, 1990, 525 (01) :36-44
[2]  
[Anonymous], ARCH NEUROL
[3]   Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia [J].
Aubert, I ;
Guigoni, C ;
Håkansson, K ;
Li, Q ;
Dovero, S ;
Barthe, N ;
Bioulac, BH ;
Gross, CE ;
Fisone, G ;
Bloch, B ;
Bezard, E .
ANNALS OF NEUROLOGY, 2005, 57 (01) :17-26
[4]   Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease [J].
Benabid, Alim Louis ;
Chabardes, Stephan ;
Mitrofanis, John ;
Pollak, Pierre .
LANCET NEUROLOGY, 2009, 8 (01) :67-81
[5]   Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of L-DOPA-Induced Dyskinesia [J].
Berthet, Amandine ;
Porras, Gregory ;
Doudnikoff, Evelyne ;
Stark, Holger ;
Cador, Martine ;
Bezard, Erwan ;
Bloch, Bertrand .
JOURNAL OF NEUROSCIENCE, 2009, 29 (15) :4829-4835
[6]   Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease [J].
Berton, Olivier ;
Guigoni, Celine ;
Li, Qin ;
Bioulac, Bernard H. ;
Aubert, Incarnation ;
Gross, Christian E. ;
DiLeone, Ralph J. ;
Nestler, Eric J. ;
Bezard, Erwan .
BIOLOGICAL PSYCHIATRY, 2009, 66 (06) :554-561
[7]   Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function [J].
Bézard, E ;
Ferry, S ;
Mach, U ;
Stark, H ;
Leriche, L ;
Boraud, T ;
Gross, C ;
Sokoloff, P .
NATURE MEDICINE, 2003, 9 (06) :762-767
[8]   Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease [J].
Bordia, Tanuja ;
Campos, Carla ;
Huang, Luping ;
Quik, Maryka .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (01) :239-247
[9]  
Brodsky MA, 2010, ARCH NEUROL-CHICAGO, V67, P27, DOI 10.1001/archneurol.2009.287
[10]   SITE-SPECIFIC ACTION OF L-3,4-DIHYDROXYPHENYLALANINE IN THE STRIATUM BUT NOT GLOBUS PALLIDUS AND SUBSTANTIA NIGRA PARS RETICULATA EVOKES DYSKINETIC MOVEMENTS IN CHRONIC L-3,4-DIHYDROXYPHENYLALANINE-TREATED 6-HYDROXYDOPAMINE-LESIONED RATS [J].
Buck, K. ;
Voehringer, P. ;
Ferger, B. .
NEUROSCIENCE, 2010, 166 (02) :355-358